| Financial Year |
March 31 2023 |
| Monetary Funds |
3,992,891,601.94 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
271,549,213.52 |
| Accounts Receivable |
1,499,937,772.84 |
| Advances to Suppliers |
392,982,983.94 |
| Other Receivables |
222,645,287.11 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
606,903,216.22 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
143,587,901.32 |
| Total Current Assets |
7,276,844,957.50 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,134,483.37 |
| Investment Properties |
54,489,440.03 |
| Fixed Assetes |
6,622,946,447.46 |
| Under-construction Projects |
376,390,696.40 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,670,275,738.64 |
| R&D expenses |
-- |
| Goodwill |
110,202,917.38 |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
263,262,819.98 |
| Other Non-Current Assets |
47,042,528.55 |
| Sub-Total of Non-Current Assets |
9,930,763,900.22 |
| Total Assets |
17,207,608,857.72 |
| Short-Term Loans |
1,185,791,971.69 |
| Trading Financial liabilities |
-- |
| Notes Payable |
129,325,661.45 |
| Accounts Payable |
1,377,393,247.53 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
32,909,826.81 |
| Taxes Payable |
248,990,310.26 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
361,333,846.82 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
92,189,895.92 |
| Other Current Liabilities |
304,413,515.75 |
| Sub-Total of Current Liabilities |
3,912,848,831.16 |
| Long-term Loans |
99,200,000.00 |
| Bonds Payable |
1,531,087,592.41 |
| Long-Term Accounts Payable |
779,073,672.50 |
| Special Payable |
-- |
| Estimatied Liabilities |
141,063,271.75 |
| Deferred Income Tax Liabilities |
45,340,751.15 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,806,133,822.39 |
| Total Liabilities |
6,718,982,653.55 |
| Paid-In Capital(Or Share Stock) |
797,402,585.00 |
| Capital Surplus |
52,632,937.47 |
| Surplus Reserve |
586,279,459.02 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
5,625,766,868.47 |
| Minority Stockholder's Interest |
3,436,449,666.41 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,052,176,537.76 |
| Owner's Equity（Stockholder's Equity） |
10,488,626,204.17 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
17,207,608,857.72 |
